A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need ...

Leading measurement and analytics company Adjust released today its annual Mobile App Trends report for 2025, showing strong momentum following the app economy's 2022 dip. Global app installs ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Wayde Cadogan, 25, from Brisbane, Australia, started noticing clumps of her blonde locks getting caught in her brush and falling out while she washed her hair in the shower. Wayde was diagnosed with ...

But one woman just shattered that illusion in the most stunning way possible. Neehar Sachdeva, a US-based fashion influencer, ...

Neehar Sachdeva, a US-based fashion influencer, is redefining beauty standards. Diagnosed with alopecia areata –– an ...